# Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.

> **NCT03163732** · NA · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 341 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **GENETIC:** Blood and tumor samples

## Key facts

- **NCT ID:** NCT03163732
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-29
- **Primary completion:** 2021-11-23
- **Final completion:** 2021-11-23
- **Target enrollment:** 341 (ACTUAL)
- **Last updated:** 2022-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163732, "Evaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03163732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*